Masimo (MASI) Capital Expenditures Growth (5y) (2014 - 2026)
Masimo (MASI) Capital Expenditures Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -13.55% |
| Sep 27, 2025 | -37.03% |
| Jun 28, 2025 | 18.08% |
| Mar 29, 2025 | -16.20% |
| Dec 28, 2024 | 108.33% |
| Sep 28, 2024 | 18.39% |
| Jun 29, 2024 | -15.77% |
| Mar 30, 2024 | -17.26% |
| Dec 30, 2023 | -57.41% |
| Sep 30, 2023 | 24.84% |
| Jul 1, 2023 | 16.59% |
| Apr 1, 2023 | 44.00% |
| Dec 31, 2022 | -15.99% |
| Oct 1, 2022 | 6.42% |
| Jul 2, 2022 | 50.41% |
| Jan 1, 2022 | -64.34% |
| Apr 3, 2021 | 10.74% |
| Mar 28, 2020 | 16.53% |
| Sep 28, 2019 | -64.21% |
| Jun 29, 2019 | -7.33% |